# Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease

> **NCT00465959** · PHASE1,PHASE2 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** trospium chloride inhalation powder (TrIP)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00465959
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465959, "Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00465959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*